Fund Holdings — GSK plc

Total Portfolio Value:
$497.01M
Total Bought:
$497.01M
Total Sold:
$0
Net Transaction:
+$497.01M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
CRISPR Therapeutics AGNAMEN AKT(CRSP)02,608,419+2,608,419$0$144.30M29.03%+$144.30M
Vir Biotechnology, Inc.(VIR)08,550,954+8,550,954$0$95.60M19.23%+$95.60M
Wave Life Sciences IncSHS018,245,691+18,245,691$0$67.51M13.58%+$67.51M
BioNTech SEADS(BNTX)0668,526+668,526$0$65.72M13.22%+$65.72M
IDEAYA Biosciences, Inc.(IDYA)01,333,333+1,333,333$0$51.23M10.31%+$51.23M
Cytokinetics, Incorporated(CYTK)0340,434+340,434$0$22.44M4.51%+$22.44M
Lyell Immunopharma Inc01,512,659+1,512,659$0$14.81M2.98%+$14.81M
Spero Therapeutics Inc09,190,606+9,190,606$0$11.12M2.24%+$11.12M
Nkarta Inc03,150,732+3,150,732$0$8.25M1.66%+$8.25M
Fulcrum Therapeutics Inc01,785,714+1,785,714$0$6.61M1.33%+$6.61M
Bicycle Therapeutics PlcADS01,529,561+1,529,561$0$5.63M1.13%+$5.63M
Regenxbio Inc0271,456+271,456$0$2.04M0.41%+$2.04M
Cvrx Inc01,007,583+1,007,583$0$1.76M0.35%+$1.76M
Page 1 of 1